Showing 301-310 of 333 grants
Title | Institution | Researcher | Program | Duration | Total Award Amount |
---|---|---|---|---|---|
Pilot Brief Communal Coping Intervention for Adults with Type 1 Diabetes | Carnegie Mellon University | Vicki Helgeson | Improving Lives | 01-July-2023 to 30-April-2026 | $600,541.30 |
Cellular Sentinels of Islet Transplant Rejection | California Institute of Technology | Mikhail Shapiro | Cures | 01-July-2023 to 30-June-2026 | $750,000.00 |
Understanding the role of scaffold microarchitecture on survival and function of stem cell-derived beta cells | Brown University | Tejal Desai | Cures | 01-October-2022 to 30-September-2025 | $474,761.58 |
Local delivery of beta-cell survival factors and immunomodulators to enable highly efficient immunosuppression-free islet transplantation | Brown University | Tejal Desai | Cures | 01-October-2022 to 01-October-2025 | $714,857.80 |
Engineered Nanobodies to Visualize and Direct Antigen-Specific Tolerance in T1D | Boston Children's Hospital | Novalia Pishesha | Cures | 01-March-2025 to 28-February-2030 | $999,999.00 |
A wireless oxygen generating immune protection device to support long term cell transplantation for the treatment of Type I Diabetes | Boston Children's Hospital | Robert Langer | Cures | 01-August-2025 to 31-July-2028 | $2,481,286.98 |
Consulting Support for Continuity Biosciences | Biologics Consulting Group, Inc. | Diana Colleluori | Cures | 01-April-2025 to 31-August-2025 | $63,475.00 |
Ad Hoc Consulting Support | Biologics Consulting Group, Inc. | Diana Colleluori | Cures | 01-July-2025 to 30-November-2025 | $61,475.00 |
New lipid biomarker to predict early risk for Type 1 diabetes | Beth Israel Deaconess Medical Center Inc | Barbara Kahn | Cures | 01-September-2024 to 31-August-2027 | $899,997.53 |
Integration of Slow-Release A1AT-loaded Nanoparticles for Enhanced Cell Therapy in Type 1 Diabetes | Beth Israel Deaconess Medical Center Inc | Giuseppe Pettinato | Cures | 01-October-2024 to 30-September-2025 | $200,000.00 |